Adam Maeder

Joshua Jennings

Frank Takkinen

Jason Wittes

Nelson Cox

- **Stereotaxis** announced it obtained **CE Mark in Europe** and submitted a **510(k) application to the FDA in the US** for its new **Synchrony™ system**.  **[1289340_75b4ff8793b748be89c67fe555ab6a19_0]** 
- The **Synchrony system** is designed to **digitize and modernize interventional cath labs** through a **55” 4K ultra-high-definition display** and streamlined workflows.  **[1289340_75b4ff8793b748be89c67fe555ab6a19_0]** 
- It is accompanied by **SynX™**, a cloud-based app providing **secure remote connectivity, collaboration, and monitoring** for cath labs.  **[1289340_75b4ff8793b748be89c67fe555ab6a19_0]** 
- The system is positioned as a foundational platform for **future innovations**, including **artificial intelligence** integration and supporting **remote long-distance robotic procedures**.  **[1289340_75b4ff8793b748be89c67fe555ab6a19_0]** **[1289340_75b4ff8793b748be89c67fe555ab6a19_1]**

Stereotaxis Announces EU Approval and US Submission for Synchrony System

- **Stereotaxis** and **CardioFocus, Inc.** have entered into a **Collaboration Agreement** to advance **robotic Pulsed Field Ablation (PFA) technology** towards commercialization for the treatment of cardiac arrhythmias.  **[1289340_a3d190940a554273bd3c7a56b2423012_0]** 
- The collaboration combines CardioFocus’ **Centauri Pulsed Field Ablation (PFA) System** with Stereotaxis’ **MAGiC robotic cardiac ablation catheter** to create the first-ever robotic PFA solution.  **[1289340_a3d190940a554273bd3c7a56b2423012_0]** 
- The companies have successfully completed **extensive bench and preclinical testing**, including pivotal preclinical studies that demonstrated safe, efficient, and impressive lesion delivery.  **[1289340_a3d190940a554273bd3c7a56b2423012_0]** 
- The agreement supports advancing this joint solution to a **clinical trial**, facilitating regulatory compatibility, and commercial availability.  **[1289340_a3d190940a554273bd3c7a56b2423012_0]**

Stereotaxis and CardioFocus Announce Collaboration for Robotic PFA Technology

- Stereotaxis successfully completed the **world's first procedures** using **MAGiC Sweep™**, a robotically-navigated high-density electrophysiology (EP) mapping catheter, at Deborah Heart and Lung Center.  **[1289340_3eeb88a511ff4541baebd4567d9cfaa8_0]** 
- The MAGiC Sweep catheter enables the creation of a **more accurate and detailed map** of complex anatomy, offering easy navigation, stable tissue contact, and clear electrogram signals.  **[1289340_3eeb88a511ff4541baebd4567d9cfaa8_0]** 
- Stereotaxis has initiated the **commercial launch** of MAGiC Sweep in the United States following recent **FDA clearance**, and it has been submitted for regulatory clearance in Europe.  **[1289340_3eeb88a511ff4541baebd4567d9cfaa8_0]**

Stereotaxis (STXS)